Scott Willis
Schlumberger Reports Small Q4 2019 Earnings Beat Driven by International Growth
Global oilfield services firm Schlumberger (NYSE: SLB) announced results that BEAT expectations. Revenue came in at $8.22 billion, 1% ahead…
Zenabis Gives Itself Some Breathing Room with Partial Conversion of Debt
Today TSX-listed Zenabis Global (TSE: ZENA) announced a partial conversion of its $17.4 million of secured debt. The lender has…
Meta Growth’s Sale of Medical Cannabis Clinics Falls Apart, What’s Next?
Meta Growth (CVE: META), formerly National Access Cannabis, announced tonight that the deal to sell their cannabis clinics division has…
OGI Smashes Expectations But Actual Results are a House of Cannabis Horrors.
Organigram (NASDAQ: OGI) beat lowered analyst estimates but dig a little deeper and the big stock price spike looks like…
Radient Enters into Sale-Leaseback Deal Amid Scarce Financing Resources
Canadian CBD product maker Radient Technologies (TSXV: RTI; OTCQX: RDDTF) today announced its decision to sell properties for C$20 million.…
Aphria (APHA) Earnings – Guidance Cut But Still the Best Game in Town
Aphria (TSE: APHA; NYSE: APHA) earnings showed it has the cash to weather the coming storm and the profitability to…
GW Pharmaceuticals Releases a Q4 Revenue Beat, but Will the Rapid Growth Continue?
Bottom Line Cannabinoid prescription medicine company GW Pharmaceuticals (NASDAQ: GWPH) pre-announced revenues for its fourth quarter and full-year last night.…
All the Reasons Why Constellation Brands Won’t Be Buying Out Canopy Growth
Constellation Brands (STZ) has neither the means nor the desire to buy Canopy Growth (CGC). Canopy must sink or swim…
Its Official: Origin House Is Now Part of Cresco Labs
Bottom Line We've covered this merger in-depth at Grizzle and thought it was highly likely the deal ended up going…